← Open Payments lookup

MATTHEW ARISMENDEZ: Open Payments

NPI 1346646510 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,121 in 65 payments from 15 companies in 2025. Trend: 2023 $1,646 · 2024 $1,392 · 2025 $1,121

Food & beverage: $1,121
CompanyPaymentsAmount
ABBVIE INC.15$219
AstraZeneca Pharmaceuticals LP5$163
Bayer Healthcare Pharmaceuticals Inc.12$154
Novo Nordisk Inc9$150
Sumitomo Pharma America, Inc.6$111
Boehringer Ingelheim Pharmaceuticals, Inc.4$66
GlaxoSmithKline, LLC.3$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$50
Seqirus USA Inc2$32
Exact Sciences Corporation1$24

Products named: Kerendia, GEMTESA, BREZTRI, Ozempic, VRAYLAR, AIRSUPRA, JARDIANCE, QULIPTA.

Industry payments across TX — which companies pay providers there.